Laws And Regulations

Type	Signature	Number	Date	Topic	Document
Circular	Minister of Public Health	9	9-3-2022	Related to providing specialized mental health medications in primary health care centers	Circular Number 9: Related to providing specialized mental health medications in primary health care centers
Decision	Minister of Public Health	271/1	25/02/2019	Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital	Decision Number 271/1: Related to the Assessment of the Health Status of Patients Transferred from Al-Fanar Hospital
Decision	Minister of Public Health	270/1	25/02/2019	Related to the Quality of Care and Human Rights in the Field of Mental Health	Decision Number 270/1: Related to the Quality of Care of Human Rights in the Field of Mental Health
Circular	Director General	60	20/06/2018	Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system	Circular Number 60: Related to the rational prescription of medication for priority mental and neurological conditions for specialists in the public health system
Circular	Director General	112	27/11/2018	Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health	Circular Number 112: Related to limiting the practice of the profession of psychologist in healthcare and educational institutions exclusively to professionals who have the license to practice from the Ministry of Public Health
Circular	Director General	113	22/11/2018	Related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)	Circular number 113: related to the mandatory licensing for the practice of the profession of Psychologist (clinical and educational)
Decision	Minister of Public Health	1155	19-06-2018	Decision related to the National Mental Health Programme	Decision number 1155: related to the National Mental Health Programme
Circular	Director General	22	09-03-2018	Regulation of studies and research in the field of mental health and psychosocial support	Circular number 22: related to the regulation of studies and research in the field of mental health and psychosocial support
Annexe		1320/1	02-2018	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.	Guidelines issued by the National Mental Health Program in the Ministry of Public Health regarding the necessary procedures and documents needed to obtain a license to practice clinical and non-clinical (educational) psychology profession.
Circular	Director General	48	12-06-2017	Regulation of research in the field of mental health	Circular number 48: Related to the regulation of research in the field of mental health
Circular	Director General	64	12-06-2017	Projects related to MHPSS and substance use in Lebanon	Circular number 64: Projects related to MHPSS and substance use in Lebanon
Circular	Director General	46	22-03-2016	Request to hospitals to not report on overdose	Circular number 46: related to the request to hospitals to not report on overdose
Circular	Director General	66	20-6-2025	Regarding Specialized Mental Health Medications	Circular number 66: Concerning Specialized Mental Health Medications

ATC	Name	B/G	Ingredients	Dosage	Form	Price
G04BD02	URISPAS	B	Flavoxate HCl - 200mg	200mg	Tablet, film coated	1,094,272 L.L
J01FA02	ROVAMYCINE	B	Spiramycin - 1.5MIU	1.5MIU	Tablet, film coated	256,674 L.L
L01CE01	HYCAMTIN IV	B	Topotecan HCl - 4mg	4mg	Injectable lyophilised powder for solution	52,580,031 L.L
M03BX02	SIRDALUD	B	Tizanidine HCl - 4mg	4mg	Tablet	890,710 L.L
S01EA05	ALPHAGAN P	B	Brimonidine tartrate - 1.5mg/ml	0.15%	Drops solution	999,819 L.L
B01AX05	ARIXTRA	B	Fondaparinux sodium - 7.5mg/0.6ml	7.5mg/0.6ml	Injectable solution	12,004,668 L.L
D07AC14	ADVANTAN	B	Methylprednisolone aceponate - 1mg/g	1mg/g	Ointment	385,683 L.L
G04BD06	MICTONORM	B	Propiverine HCl - 15mg	15mg	Tablet, coated	1,261,868 L.L
L01CE01	HYCAMTIN IV	B	Topotecan HCl - 4mg	4mg	Injectable lyophilised powder for solution	52,580,031 L.L
M03BX04	MYDOCALM	B	Tolperisone - 150mg	150mg	Tablet, film coated	839,902 L.L
A07EC02	ASACOL	B	Mesalazine - 800mg	800mg	Tablet	6,396,690 L.L
B02AA02	EXACYL	B	Tranexamic acid - 500mg/5ml	500mg/5ml	Injectable solution	748,520 L.L
D07AC14	ADVANTAN	B	Methylprednisolone aceponate - 1mg/g	1mg/g	Cream	385,683 L.L
G04BD06	MICTONORM XL	B	Propiverine HCl - 30mg	30mg	Capsule, modified release	1,648,895 L.L
N06DA02	ARICEPT	B	Donepezil HCl - 10mg	10mg	Tablet, film coated	3,776,197 L.L
A07EC02	PENTASA	B	Mesalazine - 1g	1g	Tablet, controlled release	4,945,340 L.L
A10BK01	FORXIGA	B	Dapagliflozin - 10mg	10mg	Tablet, film coated	2,927,964 L.L
C09BB04	COVERAM	B	Perindopril arginine - 10mg, Amlodipine - 5mg		Tablet	1,116,733 L.L
G04BD06	MICTONORM XL	B	Propiverine HCl - 45mg	45mg	Capsule, modified release	1,877,348 L.L
N02BE51	PANADOL MIGRAINE	B	Paracetamol - 250mg, Acetylsalicylic acid - 250mg, Caffeine - 65mg		Caplet	604,729 L.L
L01XK01	LYNPARZA	B	Olaparib - 150mg	150mg	Tablet, film coated	L.L
B02BA01	KONAKION MM PEDIATRIC	B	Phytomenadione - 2mg/0.2ml	2mg/0.2ml	Solution	442,124 L.L
D07AC18	PEITEL	B	Prednicarbate - 0.25%	0.25%	Cream	507,972 L.L
G04BD06	MICTONORM	B	Propiverine HCl - 5mg	5mg	Tablet, coated	1,917,663 L.L
J01FA09	KLACID	B	Clarithromycin - 500mg	500mg	Tablet, film coated	1,329,060 L.L
L01XG01	VELCADE	B	Bortezomib - 3.5mg	3.5mg	Injectable lyophilised powder for solution	23,616,000 L.L
L04AX04	REVLIMID	B	Lenalidomide - 10mg	10mg	Capsule	110,200,672 L.L
M04AA01	ZYLORIC	B	Allopurinol - 100mg	100mg	Tablet	278,175 L.L
L02AE04	DECAPEPTYL SR	B	Triptorelin (pamoate) - 3mg	3mg	Injectable powder for suspension+diluent	L.L
A07EC02	SALOFALK	B	Mesalazine - 1000mg	1000mg	Granules, gastro-resistant, prolonged release	3,874,298 L.L

Flavoxate HCl - 200mg

200mg

Tablet, film coated